Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1818769 | 1.00 | MEN1 (0.35) | MEN1KMT2AALDH1A1CYP3A4ALOX15 | |
| SCHEMBL3418672 | 1.00 | MEN1 (0.35) | MEN1KMT2AALDH1A1CYP3A4ALOX15 | |
| SCHEMBL12544959 | 1.00 | MEN1 (0.35) | MEN1KMT2AALDH1A1CYP3A4ALOX15 | |
| SCHEMBL686691 | 1.00 | MEN1 (0.35) | MEN1KMT2AALDH1A1CYP3A4ALOX15 | |
| SCHEMBL17220622 | 1.00 | MEN1 (0.35) | MEN1KMT2AALDH1A1CYP3A4ALOX15 | |
| Anthracene SCHEMBL27804282 | 0.98 | MEN1 (0.36) | MEN1KMT2AALDH1A1CYP3A4ALOX15 | |
| SCHEMBL29658036 | 0.96 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL325696 | 0.96 | MEN1 (0.38) | MEN1KMT2A | |
| Bromide SCHEMBL28937736 | 0.94 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL8664024 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2199437-B1 | Use of an organic semiconductor solution to form oriented polyacene crystals on a substrate | ASAHI CHEMICAL IND (JP) | 2015-07-29 | — | — | EP | disclosed |
| EP-1416069-B1 | ORGANIC SEMICONDUCTOR FILM AND METHOD FOR MANUFACTURE THEREOF | ASAHI CHEMICAL IND (JP) | 2010-10-27 | — | — | EP | disclosed |
| EP-2199437-A2 | Organic semiconductor solution | Asahi Kasei Kabushiki Kaisha (JP) | 2010-06-23 | — | — | EP | disclosed |
| US-20070026310-A1 | Redox-active reversible electrode and secondary battery using the same | Oyama, Noboru | 2007-02-01 | — | — | US | disclosed |
| EP-1744388-A1 | REDOX ACTIVE REVERSIBLE ELECTRODE AND SECONDARY BATTERY INCLUDING THE SAME | Oyama, Noboru (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-7061010-B2 | Organic semiconductor element | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2006-06-13 | — | — | US | disclosed |
| US-20050258417-A1 | Organic semicondutor element | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2005-11-24 | — | — | US | disclosed |
| EP-1416069-A1 | ORGANIC SEMICONDUCTOR ELEMENT | Asahi Kasei Kabushiki Kaisha (JP) | 2004-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070026310-A1 | Redox-active reversible electrode and secondary battery using the same | GPX1, GPX4, SQOR | MEN1 4444/4885KMT2A 2478/4885ALDH1A1 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.